CFO4Life Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.54M | Sell |
10,398
-317
| -3% | -$73.8K | 0.39% | 45 |
|
|
2025
Q4 | $2.22M | Sell |
10,715
-140
| -1% | -$27.7K | 0.32% | 51 |
|
|
2025
Q3 | $2.01M | Buy |
10,855
+179
| +2% | +$30.7K | 0.29% | 50 |
|
|
2025
Q2 | $1.63M | Buy |
10,676
+1,522
| +17% | +$234K | 0.26% | 57 |
|
|
2025
Q1 | $1.52M | Sell |
9,154
-1,030
| -10% | -$161K | 0.26% | 57 |
|
|
2024
Q4 | $1.47M | Buy |
10,184
+53
| +0.5% | +$8.21K | 0.26% | 53 |
|
|
2024
Q3 | $1.64M | Buy |
10,131
+187
| +2% | +$29.8K | 0.29% | 46 |
|
|
2024
Q2 | $1.45M | Sell |
9,944
-206
| -2% | -$30.6K | 0.27% | 47 |
|
|
2024
Q1 | $1.61M | Buy |
10,150
+96
| +1% | +$15.3K | 0.29% | 45 |
|
|
2023
Q4 | $1.58M | Sell |
10,054
-1,439
| -13% | -$221K | 0.3% | 47 |
|
|
2023
Q3 | $1.79M | Sell |
11,493
-332
| -3% | -$54.8K | 0.41% | 36 |
|
|
2023
Q2 | $1.96M | Buy |
11,825
+337
| +3% | +$54.4K | 0.42% | 35 |
|
|
2023
Q1 | $1.78M | Sell |
11,488
-624
| -5% | -$101K | 0.4% | 38 |
|
|
2022
Q4 | $2.14M | Sell |
12,112
-15
| -0.1% | -$2.59K | 0.45% | 44 |
|
|
2022
Q3 | $1.98M | Sell |
12,127
-686
| -5% | -$116K | 0.53% | 33 |
|
|
2022
Q2 | $2.23M | Buy |
12,813
+289
| +2% | +$51.5K | 0.55% | 33 |
|
|
2022
Q1 | $2.22M | Buy |
12,524
+484
| +4% | +$82.4K | 0.47% | 33 |
|
|
2021
Q4 | $2.06M | Sell |
12,040
-434
| -3% | -$71.1K | 0.43% | 36 |
|
|
2021
Q3 | $2.02M | Buy |
12,474
+2,961
| +31% | +$505K | 0.47% | 35 |
|
|
2021
Q2 | $1.57M | Buy |
9,513
+164
| +2% | +$27.2K | 0.36% | 39 |
|
|
2021
Q1 | $1.54M | Sell |
9,349
-279
| -3% | -$45.1K | 0.38% | 39 |
|
|
2020
Q4 | $1.51M | Buy |
9,628
+1,060
| +12% | +$156K | 0.43% | 35 |
|
|
2020
Q3 | $1.28M | Sell |
8,568
-970
| -10% | -$144K | 0.43% | 33 |
|
|
2020
Q2 | $1.34M | Sell |
9,538
-149
| -2% | -$21.7K | 0.52% | 32 |
|
|
2020
Q1 | $1.27M | Sell |
9,687
-76
| -0.8% | -$10.8K | 0.68% | 26 |
|
|
2019
Q4 | $1.42M | Buy |
9,763
+172
| +2% | +$23.3K | 0.6% | 31 |
|
|
2019
Q3 | $1.24M | Sell |
9,591
-2,288
| -19% | -$301K | 0.56% | 35 |
|
|
2019
Q2 | $1.66M | Sell |
11,879
-421
| -3% | -$58.3K | 0.76% | 31 |
|
|
2019
Q1 | $1.72M | Sell |
12,300
-80
| -0.6% | -$10.7K | 0.81% | 31 |
|
|
2018
Q4 | $1.6M | Buy |
12,380
+808
| +7% | +$113K | 0.7% | 34 |
|
|
2018
Q3 | $1.6M | Sell |
11,572
-525
| -4% | -$69.8K | 0.71% | 32 |
|
|
2018
Q2 | $1.47M | Buy |
12,097
+8,058
| +200% | +$1.01M | 0.61% | 34 |
|
|
2018
Q1 | $518K | Buy |
4,039
+96
| +2% | +$13K | 0.44% | 38 |
|
|
2017
Q4 | $551K | Sell |
3,943
-104
| -3% | -$14.5K | 0.43% | 38 |
|
|
2017
Q3 | $526K | Sell |
4,047
-160
| -4% | -$21.2K | 0.42% | 45 |
|
|
2017
Q2 | $557K | Buy |
4,207
+215
| +5% | +$27.4K | 0.51% | 33 |
|
|
2017
Q1 | $497K | Buy |
+3,992
| New | +$477K | 0.45% | 41 |
|
Other funds holding JNJ
VCM
VPM
CFO4Life Group's JNJ Position: Q1 2026 in Review
CFO4Life Group reduced its Johnson & Johnson (JNJ) stake by 3% in Q1 2026, selling an estimated $73.8K and leaving 10,398 shares worth $2.54M. The position accounts for 0.39% of the portfolio, ranked #45.
CFO4Life Group first reported a position in JNJ in Q1 2017 and has held it in 37 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- CFO4Life Group held 10,398 shares of Johnson & Johnson worth $2.54M as of Q1 2026.
- CFO4Life Group sold 317 Johnson & Johnson shares in Q1 2026, an estimated $73.8K.
- Johnson & Johnson made up 0.39% of CFO4Life Group's portfolio in Q1 2026, its #45 holding.
- CFO4Life Group first reported a position in Johnson & Johnson in Q1 2017 and has held it in 37 quarters since.
- 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on CFO4Life Group's 13F filing for Q1 2026, filed 11 May 2026.